FKBP10 and nonpapillary renal cell carcinoma: Based on the results, we further hypothesize that FKBP10 influences proliferation of ccRCC, reduced collagen crosslinking induced by targeted down-regulation of FKBP10 may sensitize ccRCC to adjuvant therapies.